XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0.46%14.46B | -3.79%3.4B | 3.44%3.94B | 10.11%3.49B | -6.46%3.63B | 3.26%14.39B | -7.07%3.53B | -3.86%3.81B | -11.96%3.17B | -9.25%3.88B |
Operating revenue | 7.21%14.46B | 6.35%3.4B | 0.72%3.79B | 12.18%3.46B | 2.09%3.52B | -7.32%13.49B | -10.82%3.2B | -11.28%3.76B | -18.82%3.08B | -24.08%3.45B |
Cost of revenue | 9.43%8.14B | 26.39%2.28B | -4.25%1.87B | 2.18%1.82B | 2.74%1.95B | -1.67%7.44B | -8.47%1.8B | -10.22%1.95B | -7.66%1.79B | -20.71%1.9B |
Gross profit | -9.13%6.32B | -35.26%1.12B | 11.51%2.07B | 20.35%1.66B | -15.24%1.69B | 9.11%6.96B | -5.57%1.73B | 3.85%1.86B | -16.96%1.38B | 5.24%1.99B |
Operating expense | -5.76%3.08B | -14.34%729M | -11.58%733M | 2.59%791M | 1.23%823M | 4.72%3.26B | 12.86%851M | 3.37%829M | -17.10%771M | -14.51%813M |
Depreciation amortization depletion | -9.11%2.35B | -19.01%554M | -17.69%549M | 2.31%621M | -0.16%621M | 5.65%2.58B | 12.13%684M | 5.87%667M | -12.66%607M | -10.89%622M |
-Depreciation and amortization | -9.11%2.35B | -19.01%554M | -17.69%549M | 2.31%621M | -0.16%621M | 5.65%2.58B | --684M | --667M | --607M | --622M |
Other taxes | 6.87%731M | 4.79%175M | 13.58%184M | 3.66%170M | 5.76%202M | 1.33%684M | 15.97%167M | -5.81%162M | -30.21%164M | -24.51%191M |
Operating profit | -12.10%3.25B | -55.52%391M | 30.10%1.34B | 42.79%871M | -26.64%862M | 13.31%3.69B | -18.46%879M | 4.25%1.03B | -16.78%610M | 25.27%1.18B |
Net non-operating interest income expense | -12.72%-1.89B | 27.47%-441M | -109.90%-403M | -18.73%-469M | -19.83%-574M | -67.07%-1.67B | -84.80%-608M | 46.67%-192M | -740.43%-395M | -175.29%-479M |
Non-operating interest expense | ---- | ---- | ---- | 18.73%469M | ---- | ---- | ---- | ---- | --395M | ---- |
Total other finance cost | 12.72%1.89B | -27.47%441M | 109.90%403M | ---- | 19.83%574M | 67.07%1.67B | 84.80%608M | -46.67%192M | ---- | 175.29%479M |
Other net income (expense) | 15.45%822M | -31.84%122M | 287.27%213M | -38.26%184M | 125.56%406M | 141.44%712M | 133.71%179M | -19.12%55M | 123.75%298M | 9.76%180M |
Special income (charges) | ---- | ---- | -12,100.00%-122M | -312.50%-66M | 69.79%-29M | 84.67%-280M | 79.66%-167M | -114.29%-1M | 98.48%-16M | -352.63%-96M |
-Less:Impairment of capital assets | ---- | ---- | 12,100.00%122M | 81.08%67M | -69.39%30M | -78.09%307M | -82.48%171M | -95.00%1M | -91.08%37M | 1,080.00%98M |
-Gain on sale of property,plant,equipment | ---- | ---- | --0 | -95.24%1M | -50.00%1M | 106.34%27M | -97.42%4M | --0 | 103.30%21M | -92.86%2M |
Other non- operating income (expenses) | -17.14%822M | -64.74%122M | 498.21%335M | -20.38%250M | 57.61%435M | 810.09%992M | 19.31%346M | -8.20%56M | 209.41%314M | 500.00%276M |
Income before tax | -20.13%2.18B | -84.00%72M | 28.78%1.15B | 14.23%586M | -20.78%694M | 405.93%2.73B | 106.42%450M | 28.30%893M | 190.16%513M | -5.60%876M |
Income tax | -46.43%308M | -121.70%-23M | -6.15%183M | -3.06%95M | -23.86%134M | 408.85%575M | 103.85%106M | 178.57%195M | 183.76%98M | -25.42%176M |
Net income | 3.86%2.07B | -66.30%92M | 507.64%954M | -1.89%572M | -31.29%674M | 50.95%1.99B | -4.21%273M | -79.82%157M | 228.70%583M | 37.97%981M |
Net income continuous Operations | -13.12%1.87B | -72.38%95M | 38.54%967M | 18.31%491M | -20.00%560M | 405.15%2.16B | 107.23%344M | 11.50%698M | 191.81%415M | 1.16%700M |
Net income discontinuous operations | 220.86%197M | 95.77%-3M | 97.60%-13M | -51.79%81M | -59.43%114M | -118.23%-163M | -159.66%-71M | -455.92%-541M | 16,900.00%168M | 1,378.95%281M |
Minority interest income | -53M | -53M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to the parent company | 6.52%2.12B | -46.89%145M | 507.64%954M | -1.89%572M | -31.29%674M | 50.95%1.99B | -4.21%273M | -79.82%157M | 228.70%583M | 37.97%981M |
Preferred stock dividends | -25.00%15M | 40.00%28M | 0.00%20M | -12.90%81M | 0.00%21M | 0.00%20M | 20M | -25.93%20M | ||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 11.03%2.12B | -42.46%145M | 585.40%939M | -3.37%544M | -31.95%654M | 55.78%1.91B | -4.55%252M | -81.93%137M | 224.28%563M | 40.50%961M |
Basic earnings per share | 10.42%2.5285 | -47.01%0.1726 | 600.00%1.12 | -2.99%0.65 | -32.17%0.78 | 53.69%2.29 | 747.68%0.3258 | -82.42%0.16 | 215.52%0.67 | 36.90%1.15 |
Diluted earnings per share | 6.55%2.44 | -50.00%0.15 | 600.00%1.12 | -2.99%0.65 | -32.17%0.78 | 53.69%2.29 | 528.57%0.3 | -82.42%0.16 | 215.52%0.67 | 38.55%1.15 |
Dividend per share | 0.00%2.67 | 0.00%0.6675 | 0.00%0.6675 | 0.00%0.6675 | 0.00%0.6675 | 0.00%2.67 | 0.00%0.6675 | 0.00%0.6675 | 0.00%0.6675 | 0.00%0.6675 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |